Compared to normal tissues, THBS1 and THBS2 showed higher expression in brain cancers and PAAD, but lower expression in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), OV, uterine corpus endometrial carcinoma (UCEC) and uterine carcinosarcoma (UCS). This evidence concerns the gene THBS2 and uterine corpus endometrial carcinoma.